239 related articles for article (PubMed ID: 23039364)
1. Association of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysis.
Qin X; Peng Q; Qin A; Chen Z; Lin L; Deng Y; Xie L; Xu J; Li H; Li T; Li S; Zhao J
Diagn Pathol; 2012 Oct; 7():136. PubMed ID: 23039364
[TBL] [Abstract][Full Text] [Related]
2. COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case-control studies.
Ding H; Fu Y; Chen W; Wang Z
Breast Cancer Res Treat; 2010 Aug; 123(1):265-70. PubMed ID: 20130981
[TBL] [Abstract][Full Text] [Related]
3. Association between Catechol-O-methyltransferase rs4680 (G>A) polymorphism and lung cancer risk.
Tan X; Chen M
Diagn Pathol; 2014 Oct; 9():192. PubMed ID: 25280560
[TBL] [Abstract][Full Text] [Related]
4. Association between the COMT Val158Met polymorphism and breast cancer risk: a meta-analysis of 30,199 cases and 38,922 controls.
He XF; Wei W; Li SX; Su J; Zhang Y; Ye XH; Liu Y; Wang W
Mol Biol Rep; 2012 Jun; 39(6):6811-23. PubMed ID: 22297695
[TBL] [Abstract][Full Text] [Related]
5. Association of MTHFR Ala222Val (rs1801133) polymorphism and breast cancer susceptibility: An update meta-analysis based on 51 research studies.
Yu L; Chen J
Diagn Pathol; 2012 Dec; 7():171. PubMed ID: 23217001
[TBL] [Abstract][Full Text] [Related]
6. Polymorphic catechol-O-methyltransferase gene, soy isoflavone intake and breast cancer in postmenopausal women: a case-control study.
Wang Q; Wang YP; Li JY; Yuan P; Yang F; Li H
Chin J Cancer; 2010 Jul; 29(7):683-8. PubMed ID: 20591221
[TBL] [Abstract][Full Text] [Related]
7. Limited association between a catechol-O-methyltransferase (COMT) polymorphism and breast cancer risk in Japan.
Hamajima N; Matsuo K; Tajima K; Mizutani M; Iwata H; Iwase T; Miura S; Oya H; Obata Y
Int J Clin Oncol; 2001 Feb; 6(1):13-8. PubMed ID: 11706521
[TBL] [Abstract][Full Text] [Related]
8. The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysis.
Peng Q; Lu Y; Lao X; Chen Z; Li R; Sui J; Qin X; Li S
Diagn Pathol; 2014 May; 9():100. PubMed ID: 24884893
[TBL] [Abstract][Full Text] [Related]
9. COMT Val158Met polymorphism and Parkinson's disease risk: a pooled analysis in different populations.
Wang YC; Zou YB; Xiao J; Pan CD; Jiang SD; Zheng ZJ; Yan ZR; Tang KY; Tan LM; Tang MS
Neurol Res; 2019 Apr; 41(4):319-325. PubMed ID: 30644790
[TBL] [Abstract][Full Text] [Related]
10. Association between Catechol-O-Methyltransferase Val158Met (158G/A) Polymorphism and Suicide Susceptibility: A Meta-analysis.
Sadeghiyeh T; Hosseini Biouki F; Mazaheri M; Zare-Shehneh M; Neamatzadeh H; Poursharif Z
J Res Health Sci; 2017 Jun; 17(2):e00383. PubMed ID: 28676589
[TBL] [Abstract][Full Text] [Related]
11. Association between OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and breast cancer risk: a meta-analysis.
Peng Q; Lu Y; Lao X; Chen Z; Li R; Sui J; Qin X; Li S
Diagn Pathol; 2014 Jun; 9():108. PubMed ID: 24893568
[TBL] [Abstract][Full Text] [Related]
12. No association between COMT Val158Met polymorphism and prostate cancer risk: a meta-analysis.
Zou LW; Xu XJ; Liu T; Wang HY; Fan WJ; Wang XH; Zhang ZX; Zhai JX
Genet Test Mol Biomarkers; 2013 Jan; 17(1):78-84. PubMed ID: 23116175
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between the COMT rs4680 polymorphism and ovarian cancer risk: evidence from a meta-analysis of 3,940 individuals.
Du JZ; Dong YL; Wan GX; Tao L; Lu LX; Li F; Pang LJ; Jia W
Asian Pac J Cancer Prev; 2014; 15(18):7941-5. PubMed ID: 25292091
[TBL] [Abstract][Full Text] [Related]
14. Catechol-O-methyltransferase Val 108/158 Met polymorphism in premenopausal breast cancer patients.
Sazci A; Ergul E; Utkan NZ; Canturk NZ; Kaya G
Toxicology; 2004 Nov; 204(2-3):197-202. PubMed ID: 15388245
[TBL] [Abstract][Full Text] [Related]
15. Catechol-O-methyltransferase Val158Met polymorphism and breast cancer risk in Asian population.
Li K; Li W; Zou H
Tumour Biol; 2014 Mar; 35(3):2343-50. PubMed ID: 24146281
[TBL] [Abstract][Full Text] [Related]
16. The l58Val/Met polymorphism of catechol-O-methyl transferase gene and prostate cancer risk: a meta-analysis.
Xiao L; Tong M; Jin Y; Huang W; Li Z
Mol Biol Rep; 2013 Feb; 40(2):1835-41. PubMed ID: 23096092
[TBL] [Abstract][Full Text] [Related]
17. The Catechol-O-Methyltransferase Val158Met Polymorphism Contributes to the Risk of Breast Cancer in the Chinese Population: An Updated Meta-Analysis.
Wan GX; Cao YW; Li WQ; Li YC; Li F
J Breast Cancer; 2014 Jun; 17(2):149-56. PubMed ID: 25013436
[TBL] [Abstract][Full Text] [Related]
18. Catechol-O-methyltransferase gene polymorphism and post-menopausal breast cancer risk.
Wedrén S; Rudqvist TR; Granath F; Weiderpass E; Ingelman-Sundberg M; Persson I; Magnusson C
Carcinogenesis; 2003 Apr; 24(4):681-7. PubMed ID: 12727796
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer.
Yim DS; Parkb SK; Yoo KY; Yoon KS; Chung HH; Kang HL; Ahn SH; Noh DY; Choe KJ; Jang IJ; Shin SG; Strickland PT; Hirvonen A; Kang D
Pharmacogenetics; 2001 Jun; 11(4):279-86. PubMed ID: 11434504
[TBL] [Abstract][Full Text] [Related]
20. The Association between COMT Val158Met Polymorphism and the Post-Traumatic Stress Disorder Risk: A Meta-Analysis.
Su M; Song Y
Neuropsychobiology; 2022; 81(2):156-170. PubMed ID: 34657037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
